Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $766000.0.

  • Cross Country Healthcare's Share-based Compensation fell 1195.4% to $766000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 2267.87%. This contributed to the annual value of $6.0 million for FY2024, which is 842.07% down from last year.
  • Per Cross Country Healthcare's latest filing, its Share-based Compensation stood at $766000.0 for Q3 2025, which was down 1195.4% from $870000.0 recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Share-based Compensation registered a high of $2.3 million during Q2 2024, and its lowest value of $766000.0 during Q3 2025.
  • For the 5-year period, Cross Country Healthcare's Share-based Compensation averaged around $1.6 million, with its median value being $1.6 million (2022).
  • As far as peak fluctuations go, Cross Country Healthcare's Share-based Compensation skyrocketed by 6644.74% in 2021, and later crashed by 6148.74% in 2025.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Share-based Compensation stood at $1.6 million in 2021, then skyrocketed by 33.6% to $2.2 million in 2022, then crashed by 46.68% to $1.2 million in 2023, then soared by 45.63% to $1.7 million in 2024, then crashed by 54.89% to $766000.0 in 2025.
  • Its last three reported values are $766000.0 in Q3 2025, $870000.0 for Q2 2025, and $1.3 million during Q1 2025.